Analysis shows targeted protein degradation improves cancer therapy efficacy, indicating HSP90 remains a viable therapeutic target.
Heat shock protein 90, a widely expressed molecular chaperone, has emerged as a promising anticancer target due to its crucial role in stabilizing and regulating the functions of numerous client proteins including tumor-associated proteins.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: